Breast cancer is the most common cancer among women worldwide and also represents a major challenge in Switzerland. Advances in early detection and treatment have improved survival rates, but the safe integration of digital technologies into clinical practice remains complex. With the “Lucerne Toolbox 3’” published in the journal The Lancet Oncology, researchers present 15 priority research questions that must be addressed to ensure the reliable use of AI-based methods.

The interdisciplinary network, which currently comprises 112 scientists, was founded in 2019 by Professor of Medicine Peter Dubsky. He is a titular professor of clinical medical sciences at the Faculty of Health Sciences and Medicine at the University of Lucerne and head of the Breast Centre at the Hirslanden Clinic St. Anna.

The third toolbox, co-developed by Dubsky, highlights the key prerequisites for the responsible use of AI: clear regulatory frameworks, robust ethical and data protection standards, and strong digital competencies among healthcare professionals. AI should not replace medical expertise, but rather serve as a reliable complement to enhance the quality and safety of care.

More detailed news report from the Hirslanden Clinic St. Anna (German)
Article in The Lancet Oncology
Previous news on “Lucerne Toolbox 2”